Ariz. Admin. Code § R9-6-202 – Reporting Requirements for a Health Care Provider Required to Report or an Administrator of a Health Care Institution or Correctional Facility

A. A health care provider required to report shall, either personally or through a representative, submit a report, in a Department-provided format, to the local health agency within the time limitation in Table 2.1 and as specified in subsection (C) or (D).
B. An administrator of a health care institution or correctional facility in which a case or suspect case of a communicable disease listed in Table 2.1 is diagnosed, treated, or detected or an occurrence listed in Table 2.1 is detected shall, either personally or through a representative, submit a report, in a Department-provided format, to the local health agency within the time limitation in Table 2.1 and as specified in subsection (C) or (D).
C. Except as described in subsection (D), for each case, suspect case, or occurrence for which a report on an individual is required by subsection (A) or (B) and Table 2.1, a health care provider required to report or an administrator of a health care institution or correctional facility shall submit a report that includes:
1. 1. The following information about the case or suspect case:
  1. a. Name;
  2. b. Residential and mailing addresses;
  3. c. County of residence;
  4. d. Whether the individual is living on a reservation and, if so, the name of the reservation;
  5. e. Whether the individual is affiliated with a tribe and, if so, the name of the tribe;
  6. f. Telephone number and, if available, email address;
  7. g. Date of birth;
  8. h. Race and ethnicity;
  9. i. Sex assigned at birth;
  10. j. A unique patient identifier, such as a medical record number;
2. 2. The following information about the disease:
  1. a. The name of the disease,
  2. b. The date of onset of symptoms, and
  3. c. The date of diagnosis;
3. 3. If reporting a case or suspect case of tuberculosis:
  1. a. The site of infection;
  2. b. A description of the treatment prescribed, if any, including:
    1. i. The name of each drug prescribed,
    2. ii. The dosage prescribed for each drug, and
    3. iii. The date of prescription for each drug; and
  3. c. Whether the diagnosis was confirmed by a laboratory and, if so, the name, address, and phone number of the laboratory;
4. 4. If reporting a case or suspect case of chancroid, or gonorrhea:
  1. a. A description of the treatment prescribed, if any, including:
    1. i. The name of each drug prescribed,
    2. ii. The dosage prescribed for each drug, and
    3. iii. The date of prescription for each drug;
  2. b. The site of infection;
5. 5. If reporting a case or suspect case of syphilis:
  1. a. For a case or suspect case whose sex assigned at birth is female, whether the case or suspect case is pregnant;
  2. b. The information required under subsection (C)(4); and
  3. c. Identification of the stage of the disease;
6. 6. If reporting a case of congenital syphilis in an infant, and in addition to the information required under subsections (C)(5)(b) and (c) and A.R.S. § 36-694(A), the following information:
  1. a. The name and date of birth of the individual who gave birth to the infant, and
  2. b. The residential address and telephone number of the individual who gave birth to the infant;
7. 7. If reporting a case or suspect case with one of the following, the pregnancy status of a case or suspected case whose sex assigned at birth is female:
  1. a. Hepatitis C,
  2. b. Listeriosis,
  3. c. Rubella, or
  4. d. Emerging or exotic disease;
8. 8. The name, address, telephone number, and, if available, email address of the individual making the report; and
9. 9. The name, address, telephone number, and, if available, email address of the:
  1. a. Health care provider, if reporting under subsection (A) and different from the individual specified in subsection (C)(8); or
  2. b. Health care institution or correctional facility, if reporting under subsection (B).
D. For each outbreak for which a report is required by subsection (B) and Table 2.1, an administrator of a health care institution or correctional facility shall submit a report that includes:
1. 1. A description of the signs and symptoms;
2. 2. If possible, a diagnosis and identification of suspected sources;
3. 3. The number of known cases and suspect cases;
4. 4. A description of the location and setting of the outbreak;
5. 5. The name, address, telephone number, and, if available, email address of the individual making the report; and
6. 6. The name, address, telephone number, and, if available, email address of the health care institution or correctional facility.
E. When an HIV-related test is ordered for an infant, the health care provider who orders the HIV-related test or the administrator of the health care institution in which the HIV-related test is ordered shall:
1. 1. Report the results of the infant’s HIV-related test to the Department, either personally or through a representative, within five working days after receiving the results of the HIV-related test;
2. 2. Include the following information in the report specified in subsection (E)(1):
  1. a. The name and date of birth of the infant;
  2. b. The residential address, mailing address, and telephone number of the infant;
  3. c. The name and date of birth of the individual who gave birth to the infant;
  4. d. The date of the last medical evaluation of the infant;
  5. e. The types of HIV-related tests ordered for the infant;
  6. f. The dates of the infant’s HIV-related tests;
  7. g. The results of the infant’s HIV-related tests; and
  8. h. The ordering health care provider’s name, address, and telephone number; and
3. 3. Include with the report specified in subsection (E)(1) a report for the individual who gave birth to the infant, including the following information:
  1. a. The name and date of birth of the individual who gave birth to the infant;
  2. b. The residential address, mailing address, and telephone number of the individual who gave birth to the infant;
  3. c. The date of the last medical evaluation of the individual who gave birth to the infant;
  4. d. The types of HIV-related tests ordered for the individual who gave birth to the infant;
  5. e. The dates of the HIV-related tests for the individual who gave birth to the infant;
  6. f. The results of the HIV-related tests for the individual who gave birth to the infant;
  7. g. What HIV-related risk factors the individual who gave birth to the infant has;
  8. h. Whether the individual who gave birth to the infant delivered the infant vaginally or by C-section;
  9. i. Whether the individual who gave birth to the infant was receiving HIV-related drugs prior to the infant’s birth to reduce the risk of perinatal transmission of HIV; and
  10. j. The name, address, and telephone number of the health care provider who ordered the HIV-related tests for the individual who gave birth to the infant.

Table 1. Repealed

Historical Note

New Table 1 made by final rulemaking at 10 A.A.R. 3559, effective October 2, 2004 (Supp. 04-3). Table 1 amended by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2). Table 1 repealed by final rulemaking at 23 A.A.R. 2605, effective January 1, 2018 (Supp. 17-3).

Table 2.1. Reporting Requirements for a Health Care Provider Required to Report or an Administrator of a Health Care Institution or Correctional Facility

🗲	Anthrax	!	Hantavirus infection	!	Rubella (German measles)
🗲	Botulism	!	Hemolytic uremic syndrome	!	Rubella syndrome, congenital
!	Brucellosis	🖳	HIV infection and related disease in an infant	🗲	Severe acute respiratory syndrome (SARS)
!	Candida auris	!	Influenza-associated mortality in a child	🗲	Smallpox
🖳	Chancroid	!	Leptospirosis	!	Spotted fever rickettsiosis (e.g., Rocky Mountain spotted fever)
!	Chikungunya	!	Listeriosis	🖳1	Syphilis
!	Cholera	!	Lymphocytic choriomeningitis	🖳	Taeniasis
🖳	Creutzfeldt-Jakob disease	🗲	Measles (rubeola)	🖳	Tetanus
🗲	Cronobacter infection in an infant	!	Melioidosis	🖳	Toxic shock syndrome
🖳	Cysticercosis	🗲	Meningococcal invasive disease	!	Trichinosis
!	Dengue	🗲	Middle East respiratory syndrome (MERS)	!	Tuberculosis, active disease
O	Diarrhea, nausea, or vomiting	🖳	Mpox	!	Tuberculosis latent infection in a child 5 years of age or younger
🗲	Diphtheria	!	Mumps	🗲	Tularemia
🗲	Emerging or exotic disease	🗲	Novel coronavirus infection	!	Typhoid fever
🗲	Encephalitis, parasitic	!	Pertussis (whooping cough)	!	Typhus fever
!	Encephalitis, viral	🗲	Plague	!	Vaccinia-related adverse event
🗲	Glanders	🗲	Poliomyelitis (paralytic or non-paralytic)	🖳	Varicella (chickenpox)
🖳	Gonorrhea	!	Q fever	🗲	Viral hemorrhagic fever
!	Haemophilus influenzae, invasive disease	🗲	Rabies in a human	🗲	Yellow fever
🖳	Hansen’s disease (Leprosy)	!	Relapsing fever (borreliosis)	!	Zika virus infection
		O	Respiratory disease

Key:

🗲 Submit a report through an electronic reporting system authorized by the Department or by telephone within 24 hours after a case or suspect case is diagnosed, treated, or detected or an occurrence is detected.

! Submit a report within one working day through an electronic reporting system or by telephone after a case or suspect case is diagnosed, treated, or detected.

🖳 Submit a report within five working days after a case or suspect case is diagnosed, treated, or detected.

O Submit a report within 24 hours after detecting an outbreak.

Footnote:

1 Submit a report within one working day if the case or suspect case is a pregnant woman.

Historical Note

New Table 2.1 made by final rulemaking at 23 A.A.R. 2605, effective January 1, 2018 (Supp. 17-3). Amended by final rulemaking at 31 A.A.R. 1317 (April 25, 2025), effective June 2, 2025 (Supp. 25-2).

Historical Note

Renumbered from R9-6-213 and amended effective May 2, 1991 (Supp. 91-2). Former Section R9-6-202 renumbered to R9-6-502, new Section R9-6-202 renumbered from R9-6-602 and amended effective October 19, 1993 (Supp. 93-4). Amended effective April 4, 1997 (Supp. 97-2). Amended by final rulemaking at 8 A.A.R. 4467, effective December 1, 2002 (Supp. 02-4). Amended by final rulemaking at 10 A.A.R. 3559, effective October 2, 2004 (Supp. 04-3). Amended by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2). Amended by final rulemaking at 23 A.A.R. 2605, effective January 1, 2018 (Supp. 17-3). Amended by final rulemaking at 31 A.A.R. 1317 (April 25, 2025), effective June 2, 2025 (Supp. 25-2).